Report overview
Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in various forms, such as pills, tablets, capsules and injections. Botanical drugs, such as aescin, adoniside, atropine and berberine, are derived from plants. These drugs are used as an important component of traditional medicine and therapies, such as homeopathy and ayurvedic medicines. Some of the major classes of plant drugs are terpenes, steroids, glycosides and phenols.
This report aims to provide a comprehensive presentation of the global market for Botanical and Plant Derived Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botanical and Plant Derived Drugs. This report contains market size and forecasts of Botanical and Plant Derived Drugs in global, including the following market information:
Global Botanical and Plant Derived Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Botanical and Plant Derived Drugs market was valued at US$ 28950 million in 2022 and is projected to reach US$ 36700 million by 2029, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Globally, increased usage of botanical drugs as an alternative to synthetic medicine and increasing prevalence of various chronic diseases are some of the major drivers for growth of botanical and plant derived drugs. In addition, low cost of botanical drugs and technological advancement in production procedure of botanical drugs are also supporting in growth of botanical and plant derived drugs market. However, stringent laws and regulations for approval of botanical drugs is a key restraint for botanical and plant derived drugs market.
We surveyed the Botanical and Plant Derived Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Botanical and Plant Derived Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Botanical and Plant Derived Drugs Market Segment Percentages, by Type, 2022 (%)
Tablets
Capsules
Pills
Injections
Global Botanical and Plant Derived Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Botanical and Plant Derived Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Global Botanical and Plant Derived Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Botanical and Plant Derived Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Botanical and Plant Derived Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Botanical and Plant Derived Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abott Laboratories
Bayer Healthcare
Bionova
Bristol Myers
Curapharm
Outline of Major Chapters:
Chapter 1: Introduces the definition of Botanical and Plant Derived Drugs, market overview.
Chapter 2: Global Botanical and Plant Derived Drugs market size in revenue.
Chapter 3: Detailed analysis of Botanical and Plant Derived Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Botanical and Plant Derived Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
